Smartleaf Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.2K Hold
834
﹤0.01% 1511
2026
Q1
$25.4K Sell
834
-270
-24% -$9.99K ﹤0.01% 1817
2025
Q4
$46.7K Buy
1,104
+679
+160% +$27.4K ﹤0.01% 1583
2025
Q3
$14.3K Buy
425
+276
+185% +$7.92K ﹤0.01% 1960
2025
Q2
$4.08K Sell
149
-65
-30% -$1.88K ﹤0.01% 2115
2025
Q1
$6.45K Sell
214
-197
-48% -$7.51K ﹤0.01% 2099
2024
Q4
$16.4K Buy
411
+199
+94% +$7.54K ﹤0.01% 1755
2024
Q3
$7.16K Buy
212
+163
+333% +$4.59K ﹤0.01% 1955
2024
Q2
$1.08K Buy
+49
New +$1.03K ﹤0.01% 2403

Other funds holding VCYT

Smartleaf Asset Management's VCYT Position: Q2 2026 in Review

Smartleaf Asset Management held its Veracyte (VCYT) position steady in Q2 2026 at 834 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Smartleaf Asset Management first reported a position in VCYT in Q2 2024 and has held it in 9 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Smartleaf Asset Management held 834 shares of Veracyte worth $50.2K as of Q2 2026.
  • Smartleaf Asset Management left its Veracyte share count unchanged in Q2 2026.
  • Veracyte made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1511 holding.
  • Smartleaf Asset Management first reported a position in Veracyte in Q2 2024 and has held it in 9 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.